Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Weiss

Showing results (91-100 of 138) with videos related to

Pageof 14
Sort By:
Journal of Drugs in Dermatology : JDD|March 15, 2018
Efficacy and Safety of Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel Plus Oral Doxycycline in Subjects With Severe Inflammatory Acne Who Are Candidates for Oral IsotretinoinJames Q Del Rosso, Linda Stein Gold, Sandra Marchese Johnson, et al.
Journal of Drugs in Dermatology : JDD|September 20, 2005
A large 12-month extension study of an 8-week trial to evaluate the safety and efficacy of triple combination (TC) cream in melasma patients previously treated with TC cream or one of its dyadsHelen Torok, Susan Taylor, Leslie Baumann, et al.
Journal of Applied Research in Intellectual Disabilities : JARID|April 29, 2026
Community Implementation of a Clinician and Caregiver Co-Led Programme to Promote the Wellbeing of Family Caregivers of Individuals With Intellectual and Developmental DisabilitiesAvra Selick, Soumya Mishra, Louisa Lok Yee Man, et al.
Cutis|October 2, 2002
Effective treatment of actinic keratosis with 0.5% fluorouracil cream for 1, 2, or 4 weeksJonathan Weiss, Alan Menter, Oscar Hevia, et al.
Leukemia & Lymphoma|June 9, 2025
Cost effectiveness of mosunetuzumab and CAR-T cell therapy in relapsed/refractory follicular lymphomaMeng-Hsuan Lin, Jonathan Weiss, Tycel J Phillips, et al.
Journal of the American Academy of Dermatology|November 1, 2011
Acne severity grading: determining essential clinical components and features using a Delphi consensusJerry Tan, Barat Wolfe, Jonathan Weiss, et al.
JAAD International|November 24, 2021
Identifying gaps and providing recommendations to address shortcomings in the investigation of acne sequelae by the Personalising Acne: Consensus of Experts panelAlison Layton, Andrew Alexis, Hilary Baldwin, et al.
Journal of Drugs in Dermatology : JDD|March 5, 2015
Evolving perspectives on the etiology and pathogenesis of acne vulgarisLawrence F Eichenfield, James Q Del Rosso, Anthony J Mancini, et al.
The British Journal of Dermatology|May 12, 2024
Secukinumab in adult patients with lichen planus: efficacy and safety results from the randomized placebo-controlled proof-of-concept PRELUDE studyThierry Passeron, Maximilian Reinhardt, Benjamin Ehst, et al.
JAMA Dermatology|April 3, 2024
Barriers and Facilitators Affecting Long-Term Antibiotic Prescriptions for Acne TreatmentRonnie A Festok, Avni S Ahuja, Jared Y Chen, et al.
Pageof 14

Showing results (91-100 of 138) with videos related to

Sort By:
Pageof 14
Journal of Drugs in Dermatology : JDD|March 15, 2018
Efficacy and Safety of Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel Plus Oral Doxycycline in Subjects With Severe Inflammatory Acne Who Are Candidates for Oral IsotretinoinJames Q Del Rosso, Linda Stein Gold, Sandra Marchese Johnson, et al.
Journal of Drugs in Dermatology : JDD|September 20, 2005
A large 12-month extension study of an 8-week trial to evaluate the safety and efficacy of triple combination (TC) cream in melasma patients previously treated with TC cream or one of its dyadsHelen Torok, Susan Taylor, Leslie Baumann, et al.
Journal of Applied Research in Intellectual Disabilities : JARID|April 29, 2026
Community Implementation of a Clinician and Caregiver Co-Led Programme to Promote the Wellbeing of Family Caregivers of Individuals With Intellectual and Developmental DisabilitiesAvra Selick, Soumya Mishra, Louisa Lok Yee Man, et al.
Cutis|October 2, 2002
Effective treatment of actinic keratosis with 0.5% fluorouracil cream for 1, 2, or 4 weeksJonathan Weiss, Alan Menter, Oscar Hevia, et al.
Leukemia & Lymphoma|June 9, 2025
Cost effectiveness of mosunetuzumab and CAR-T cell therapy in relapsed/refractory follicular lymphomaMeng-Hsuan Lin, Jonathan Weiss, Tycel J Phillips, et al.
Journal of the American Academy of Dermatology|November 1, 2011
Acne severity grading: determining essential clinical components and features using a Delphi consensusJerry Tan, Barat Wolfe, Jonathan Weiss, et al.
JAAD International|November 24, 2021
Identifying gaps and providing recommendations to address shortcomings in the investigation of acne sequelae by the Personalising Acne: Consensus of Experts panelAlison Layton, Andrew Alexis, Hilary Baldwin, et al.
Journal of Drugs in Dermatology : JDD|March 5, 2015
Evolving perspectives on the etiology and pathogenesis of acne vulgarisLawrence F Eichenfield, James Q Del Rosso, Anthony J Mancini, et al.
The British Journal of Dermatology|May 12, 2024
Secukinumab in adult patients with lichen planus: efficacy and safety results from the randomized placebo-controlled proof-of-concept PRELUDE studyThierry Passeron, Maximilian Reinhardt, Benjamin Ehst, et al.
JAMA Dermatology|April 3, 2024
Barriers and Facilitators Affecting Long-Term Antibiotic Prescriptions for Acne TreatmentRonnie A Festok, Avni S Ahuja, Jared Y Chen, et al.
Pageof 14